| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |